Status and phase
Conditions
Treatments
About
The purpose of ALLEGRO-HTN trial is to evaluate the safety and effectiveness of renal denervation in subjects with resistant hypertension by using Allegro renal denervation system
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Angiographic Exclusion Criteria:
Primary purpose
Allocation
Interventional model
Masking
3 participants in 2 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal